{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:06:16Z","timestamp":1761660376801,"version":"build-2065373602"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Shandong Province for the General Program","award":["ZR2020MH339"],"award-info":[{"award-number":["ZR2020MH339"]}]},{"name":"Abroad Program for Shandong Provincial Government Education System","award":["2022-44"],"award-info":[{"award-number":["2022-44"]}]},{"name":"Overseas Study Fund Program for Shandong First Medical University & Shandong Academy of Medical Sciences"},{"name":"Academic Promotion Program of School of Public Health of Shandong First Medical University","award":["GW202218"],"award-info":[{"award-number":["GW202218"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10067-025-07639-x","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T22:53:05Z","timestamp":1757890385000},"page":"4517-4528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between immunoglobulin G N-glycosylation, inflammatory factors, and ankylosing spondylitis: A case\u2013control study"],"prefix":"10.1007","volume":"44","author":[{"given":"Jia","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangshen","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-3863","authenticated-orcid":false,"given":"Guoyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"3","key":"7639_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18502\/jovr.v16i3.9440","volume":"16","author":"N Ebrahimiadib","year":"2021","unstructured":"Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG (2021) Ankylosing spondylitis. J Ophthalmic Vis Res 16(3):462\u2013469. https:\/\/doi.org\/10.18502\/jovr.v16i3.9440","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"7639_CR2","doi-asserted-by":"publisher","first-page":"e52559","DOI":"10.7759\/cureus.52559","volume":"16","author":"P Agrawal","year":"2024","unstructured":"Agrawal P, Tote S, Sapkale B (2024) Diagnosis and treatment of ankylosing spondylitis. Cureus 16(1):e52559. https:\/\/doi.org\/10.7759\/cureus.52559","journal-title":"Cureus"},{"issue":"12","key":"7639_CR3","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1007\/s10067-021-05864-8","volume":"40","author":"T Korotaeva","year":"2021","unstructured":"Korotaeva T, Dina O, Holdsworth E, Fallon L, Milligan G, Meakin S et al (2021) Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study. Clin Rheumatol 40(12):4915\u20134926. https:\/\/doi.org\/10.1007\/s10067-021-05864-8","journal-title":"Clin Rheumatol"},{"key":"7639_CR4","doi-asserted-by":"publisher","first-page":"602334","DOI":"10.3389\/fpubh.2020.602334","volume":"8","author":"L Tu","year":"2020","unstructured":"Tu L, Xie Y, Liao Z, Jiang Y, Lv Q, Cao S et al (2020) Cost of illness, quality of life, and work outcomes in active ankylosing spondylitis patients treated with adalimumab in China. Front Public Health 8:602334. https:\/\/doi.org\/10.3389\/fpubh.2020.602334","journal-title":"Front Public Health"},{"issue":"5","key":"7639_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","volume":"21","author":"M Garrido-Cumbrera","year":"2019","unstructured":"Garrido-Cumbrera M, Poddubnyy D, Gossec L, G\u00e1lvez-Ruiz D, Bundy C, Mahapatra R et al (2019) The European map of axial spondyloarthritis: capturing the patient perspective-an analysis of 2846 patients across 13 countries. Curr Rheumatol Rep 21(5):19. https:\/\/doi.org\/10.1007\/s11926-019-0819-8","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"7639_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53(4):650\u2013657. https:\/\/doi.org\/10.1093\/rheumatology\/ket387","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7639_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-020-04537-0","volume":"40","author":"J Zhao","year":"2020","unstructured":"Zhao J, Huang C, Huang H, Pan JK, Zeng LF, Luo MH et al (2020) Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis. Rheumatol Int 40(6):859\u2013872. https:\/\/doi.org\/10.1007\/s00296-020-04537-0","journal-title":"Rheumatol Int"},{"key":"7639_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05733-y","author":"VK Bournia","year":"2024","unstructured":"Bournia VK, Fragoulis GE, Mitrou P, Tsolakidis A, Mathioudakis K, Vassilopoulos D et al (2024) Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020\u20132023 versus 2016\u20132019 in a nation-wide cohort study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-024-05733-y","journal-title":"Rheumatol Int"},{"issue":"8","key":"7639_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41584-020-0450-0","volume":"16","author":"MA Brown","year":"2020","unstructured":"Brown MA, Li Z, Cao KL (2020) Biomarker development for axial spondyloarthritis. Nat Rev Rheumatol 16(8):448\u2013463. https:\/\/doi.org\/10.1038\/s41584-020-0450-0","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"7639_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41436-019-0647-2","volume":"22","author":"J Verheijen","year":"2019","unstructured":"Verheijen J, Tahata S, Kozicz T, Witters P, Morava E (2019) Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update. Genet Med 22(2):268\u2013279. https:\/\/doi.org\/10.1038\/s41436-019-0647-2","journal-title":"Genet Med"},{"key":"7639_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2021.02.001","volume":"105","author":"S Liu","year":"2021","unstructured":"Liu S, Liu X (2021) IgG N-glycans. Adv Clin Chem 105:1\u201347. https:\/\/doi.org\/10.1016\/bs.acc.2021.02.001","journal-title":"Adv Clin Chem"},{"issue":"4","key":"7639_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/glycob\/cwz042","volume":"30","author":"JJ Du","year":"2020","unstructured":"Du JJ, Klontz EH, Guerin ME, Trastoy B, Sundberg EJ (2020) Structural insights into the mechanisms and specificities of IgG-active endoglycosidases. Glycobiology 30(4):268\u2013279. https:\/\/doi.org\/10.1093\/glycob\/cwz042","journal-title":"Glycobiology"},{"issue":"11","key":"7639_CR13","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/jci82695","volume":"125","author":"I Quast","year":"2015","unstructured":"Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX et al (2015) Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest 125(11):4160\u20134170. https:\/\/doi.org\/10.1172\/jci82695","journal-title":"J Clin Invest"},{"key":"7639_CR14","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1038\/srep04347","volume":"4","author":"M Novokmet","year":"2014","unstructured":"Novokmet M, Luki\u0107 E, Vu\u010dkovi\u0107 F, \u00d0uri\u0107 \u017d, Keser T, Raj\u0161l K et al (2014) Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep 4:4347. https:\/\/doi.org\/10.1038\/srep04347","journal-title":"Sci Rep"},{"key":"7639_CR15","doi-asserted-by":"publisher","first-page":"28207","DOI":"10.1038\/srep28207","volume":"6","author":"SE de Jong","year":"2016","unstructured":"de Jong SE, Selman MH, Adegnika AA, Amoah AS, van Riet E, Kruize YC et al (2016) IgG1 Fc n-glycan galactosylation as a biomarker for immune activation. Sci Rep 6:28207. https:\/\/doi.org\/10.1038\/srep28207","journal-title":"Sci Rep"},{"issue":"1","key":"7639_CR16","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1038\/s41598-017-12495-0","volume":"7","author":"R Plomp","year":"2017","unstructured":"Plomp R, Ruhaak LR, Uh HW, Reiding KR, Selman M, Houwing-Duistermaat JJ et al (2017) Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci Rep 7(1):12325. https:\/\/doi.org\/10.1038\/s41598-017-12495-0","journal-title":"Sci Rep"},{"issue":"17","key":"7639_CR17","doi-asserted-by":"publisher","first-page":"e3379","DOI":"10.1097\/MD.0000000000003379","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y, Klaric L, Yu X, Thaqi K, Dong J, Novokmet M et al (2016) The association between glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional study. Medicine 95(17):e3379. https:\/\/doi.org\/10.1097\/MD.0000000000003379","journal-title":"Medicine"},{"issue":"12","key":"7639_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/omi.2019.0075","volume":"23","author":"X Li","year":"2019","unstructured":"Li X, Wang H, Russell A, Cao W, Wang X, Ge S et al (2019) Type 2 diabetes mellitus is associated with the immunoglobulin G N-glycome through putative proinflammatory mechanisms in an Australian population. OMICS 23(12):631\u2013639. https:\/\/doi.org\/10.1089\/omi.2019.0075","journal-title":"OMICS"},{"issue":"5","key":"7639_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/glycob\/cwx022","volume":"27","author":"AC Russell","year":"2017","unstructured":"Russell AC, Simurina M, Garcia MT, Novokmet M, Wang Y, Rudan I et al (2017) The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson\u2019s disease. Glycobiology 27(5):501\u2013510. https:\/\/doi.org\/10.1093\/glycob\/cwx022","journal-title":"Glycobiology"},{"issue":"12","key":"7639_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/omi.2019.0099","volume":"23","author":"H Wang","year":"2019","unstructured":"Wang H, Li X, Wang X, Liu D, Zhang X, Cao W et al (2019) Next-generation (glycomic) biomarkers for cardiometabolic health: a community-based study of immunoglobulin G N-glycans in a Chinese Han population. OMICS 23(12):649\u2013659. https:\/\/doi.org\/10.1089\/omi.2019.0099","journal-title":"OMICS"},{"issue":"6","key":"7639_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/omi.2016.0050","volume":"20","author":"A Sebastian","year":"2016","unstructured":"Sebastian A, Alzain MA, Asweto CO, Song H, Cui L, Yu X et al (2016) Glycan biomarkers for rheumatoid arthritis and its remission status in Han Chinese patients. OMICS 20(6):343\u2013351. https:\/\/doi.org\/10.1089\/omi.2016.0050","journal-title":"OMICS"},{"issue":"11","key":"7639_CR22","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/art.39273","volume":"67","author":"F Vu\u010dkovi\u0107","year":"2015","unstructured":"Vu\u010dkovi\u0107 F, Kri\u0161ti\u0107 J, Gudelj I, Teruel M, Keser T, Pezer M et al (2015) Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 67(11):2978\u20132989. https:\/\/doi.org\/10.1002\/art.39273","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"7639_CR23","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1039\/c8an02014k","volume":"144","author":"D Sun","year":"2019","unstructured":"Sun D, Hu F, Gao H, Song Z, Xie W, Wang P et al (2019) Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS(n). Analyst 144(6):2042\u20132051. https:\/\/doi.org\/10.1039\/c8an02014k","journal-title":"Analyst"},{"issue":"1","key":"7639_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"HS Hreggvidsdottir","year":"2014","unstructured":"Hreggvidsdottir HS, Noordenbos T, Baeten DL (2014) Inflammatory pathways in spondyloarthritis. Mol Immunol 57(1):28\u201337. https:\/\/doi.org\/10.1016\/j.molimm.2013.07.016","journal-title":"Mol Immunol"},{"issue":"suppl_6","key":"7639_CR25","doi-asserted-by":"publisher","first-page":"vi4","DOI":"10.1093\/rheumatology\/key001","volume":"57","author":"D Simone","year":"2018","unstructured":"Simone D, Al Mossawi MH, Bowness P (2018) Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford) 57(suppl_6):vi4\u2013vi9. https:\/\/doi.org\/10.1093\/rheumatology\/key001","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7639_CR26","first-page":"971","volume":"26","author":"M Dougados","year":"1999","unstructured":"Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26(4):971\u2013974","journal-title":"J Rheumatol"},{"key":"7639_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.imlet.2018.01.014","volume":"196","author":"F Babaie","year":"2018","unstructured":"Babaie F, Hasankhani M, Mohammadi H, Safarzadeh E, Rezaiemanesh A, Salimi R et al (2018) The role of gut microbiota and IL-23\/IL-17 pathway in ankylosing spondylitis immunopathogenesis: new insights and updates. Immunol Lett 196:52\u201362. https:\/\/doi.org\/10.1016\/j.imlet.2018.01.014","journal-title":"Immunol Lett"},{"key":"7639_CR28","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F et al (2021) Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol 12:637829. https:\/\/doi.org\/10.3389\/fimmu.2021.637829","journal-title":"Front Immunol"},{"issue":"4","key":"7639_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4078\/jrd.2023.0041","volume":"30","author":"SH Kim","year":"2023","unstructured":"Kim SH, Lee SH (2023) Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. J Rheum Dis 30(4):220\u2013233. https:\/\/doi.org\/10.4078\/jrd.2023.0041","journal-title":"J Rheum Dis"},{"issue":"4","key":"7639_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27(4):361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum."},{"key":"7639_CR31","doi-asserted-by":"publisher","first-page":"e60104","DOI":"10.3791\/60104","volume":"155","author":"D Liu","year":"2020","unstructured":"Liu D, Xu X, Li Y, Zhang J, Zhang X, Li Q et al (2020) Immunoglobulin G N-Glycan analysis by ultra-performance liquid chromatography. J Vis Exp 155:e60104. https:\/\/doi.org\/10.3791\/60104","journal-title":"J Vis Exp"},{"issue":"5","key":"7639_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14789450.2016.1174584","volume":"13","author":"I Trbojevi\u0107-Akma\u010di\u0107","year":"2016","unstructured":"Trbojevi\u0107-Akma\u010di\u0107 I, Vilaj M, Lauc G (2016) High-throughput analysis of immunoglobulin G glycosylation. Expert Rev Proteomics 13(5):523\u2013534. https:\/\/doi.org\/10.1080\/14789450.2016.1174584","journal-title":"Expert Rev Proteomics"},{"issue":"10","key":"7639_CR33","doi-asserted-by":"publisher","first-page":"M111.010090","DOI":"10.1074\/mcp.M111.010090","volume":"10","author":"M Puci\u0107","year":"2011","unstructured":"Puci\u0107 M, Knezevi\u0107 A, Vidic J, Adamczyk B, Novokmet M, Polasek O et al (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10(10):M111.010090. https:\/\/doi.org\/10.1074\/mcp.M111.010090","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"7639_CR34","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.7150\/jca.31380","volume":"10","author":"R Qin","year":"2019","unstructured":"Qin R, Yang Y, Qin W, Han J, Chen H, Zhao J et al (2019) The value of serum immunoglobulin G glycome in the preoperative discrimination of peritoneal metastasis from advanced gastric cancer. J Cancer 10(12):2811\u20132821. https:\/\/doi.org\/10.7150\/jca.31380","journal-title":"J Cancer"},{"key":"7639_CR35","doi-asserted-by":"crossref","unstructured":"Wang TT (2019) IgG Fc glycosylation in human immunity. In: Ravetch JV, Nimmerjahn F (eds) Fc Mediated Activity of Antibodies: Structural and Functional Diversity. Springer International Publishing, Cham, pp 63\u201375","DOI":"10.1007\/82_2019_152"},{"issue":"5787","key":"7639_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313(5787):670\u2013673. https:\/\/doi.org\/10.1126\/science.1129594","journal-title":"Science"},{"issue":"7","key":"7639_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F (2021) Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17(7):387\u2013404. https:\/\/doi.org\/10.1038\/s41584-021-00625-y","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7639_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0272989x0102100103","volume":"21","author":"A Robinson","year":"2001","unstructured":"Robinson A, Loomes G, Jones-Lee M (2001) Visual analog scales, standard gambles, and relative risk aversion. Med Decis Making 21(1):17\u201327. https:\/\/doi.org\/10.1177\/0272989x0102100103","journal-title":"Med Decis Making"},{"issue":"12","key":"7639_CR39","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"7","key":"7639_CR40","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/annrheumdis-2012-202976","volume":"73","author":"C Fern\u00e1ndez-Espartero","year":"2014","unstructured":"Fern\u00e1ndez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA et al (2014) Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis 73(7):1350\u20131355. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202976","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"7639_CR41","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"key":"7639_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tmsr.2022.01.001","volume":"5","author":"X Xu","year":"2022","unstructured":"Xu X, Balmer L, Chen Z, Mahara G, Lin L (2022) The role of IgG N-galactosylation in spondyloarthritis. Translational Metabolic Syndrome Research 5:16\u201323","journal-title":"Translational Metabolic Syndrome Research"},{"issue":"5","key":"7639_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/annrheumdis-2018-213815","volume":"78","author":"J Wang","year":"2019","unstructured":"Wang J, Wang C, Liang Y, Pan H, Jiang Z, Li Z et al (2019) Serum IgG n-glycans act as novel serum biomarkers of ankylosing spondylitis. Ann Rheum Dis 78(5):705\u2013707. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213815","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7639_CR44","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s10067-020-04998-5","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Zhu Q, Han J, Zhang H, Li Y, Ma Y et al (2020) The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score. Clin Rheumatol 39(8):2317\u20132323. https:\/\/doi.org\/10.1007\/s10067-020-04998-5","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7639_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10020-019-0093-2","volume":"25","author":"J Liu","year":"2019","unstructured":"Liu J, Zhu Q, Han J, Zhang H, Li Y, Ma Y et al (2019) IgG galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis. Mol Med 25(1):25. https:\/\/doi.org\/10.1186\/s10020-019-0093-2","journal-title":"Mol Med"},{"issue":"9","key":"7639_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.2862","volume":"18","author":"CM Karsten","year":"2012","unstructured":"Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M et al (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc\u03b3RIIB and dectin-1. Nat Med 18(9):1401\u20131406. https:\/\/doi.org\/10.1038\/nm.2862","journal-title":"Nat Med"},{"issue":"10","key":"7639_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrgastro.2014.78","volume":"11","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pu\u010di\u0107-Bakovi\u0107 M, Zoldo\u0161 V et al (2014) The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 11(10):588\u2013600. https:\/\/doi.org\/10.1038\/nrgastro.2014.78","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7639_CR48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","volume":"8","author":"B Peschke","year":"2017","unstructured":"Peschke B, Keller CW, Weber P, Quast I, L\u00fcnemann JD (2017) Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front Immunol 8:646. https:\/\/doi.org\/10.3389\/fimmu.2017.00646","journal-title":"Front Immunol"},{"issue":"1","key":"7639_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbrc.2016.09.038","volume":"479","author":"KA Heyl","year":"2016","unstructured":"Heyl KA, Karsten CM, Slevogt H (2016) Galectin-3 binds highly galactosylated IgG1 and is crucial for the IgG1 complex mediated inhibition of C5areceptor induced immune responses. Biochem Biophys Res Commun 479(1):86\u201390. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.038","journal-title":"Biochem Biophys Res Commun"},{"key":"7639_CR50","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.1038\/ncomms11205","volume":"7","author":"Y Ohmi","year":"2016","unstructured":"Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y et al (2016) Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun 7:11205. https:\/\/doi.org\/10.1038\/ncomms11205","journal-title":"Nat Commun"},{"key":"7639_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ebiom.2017.01.033","volume":"17","author":"MJ Kemna","year":"2017","unstructured":"Kemna MJ, Plomp R, van Paassen P, Koeleman CAM, Jansen BC, Damoiseaux J et al (2017) Galactosylation and sialylation levels of IgG predict relapse in patients with PR3-ANCA associated vasculitis. EBioMedicine 17:108\u2013118. https:\/\/doi.org\/10.1016\/j.ebiom.2017.01.033","journal-title":"EBioMedicine"},{"issue":"3","key":"7639_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00281-012-0308-x","volume":"34","author":"S B\u00f6hm","year":"2012","unstructured":"B\u00f6hm S, Schwab I, Lux A, Nimmerjahn F (2012) The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol 34(3):443\u2013453. https:\/\/doi.org\/10.1007\/s00281-012-0308-x","journal-title":"Semin Immunopathol"},{"key":"7639_CR53","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre U, Lang SC, Pfeifle R, Rombouts Y, Fr\u00fchbei\u00dfer S, Amara K et al (2015) Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun 6:6651. https:\/\/doi.org\/10.1038\/ncomms7651","journal-title":"Nat Commun"},{"issue":"4\u20135","key":"7639_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1155\/2008\/264594","volume":"25","author":"A Mehta","year":"2008","unstructured":"Mehta A, Block TM (2008) Fucosylated glycoproteins as markers of liver disease. Dis Markers 25(4\u20135):259\u2013265. https:\/\/doi.org\/10.1155\/2008\/264594","journal-title":"Dis Markers"},{"issue":"23","key":"7639_CR55","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.3748\/wjg.v25.i23.2947","volume":"25","author":"PA Norton","year":"2019","unstructured":"Norton PA, Mehta AS (2019) Expression of genes that control core fucosylation in hepatocellular carcinoma: systematic review. World J Gastroenterol 25(23):2947\u20132960. https:\/\/doi.org\/10.3748\/wjg.v25.i23.2947","journal-title":"World J Gastroenterol"},{"issue":"1","key":"7639_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10719-011-9364-z","volume":"29","author":"K Kodar","year":"2012","unstructured":"Kodar K, Stadlmann J, Klaamas K, Sergeyev B, Kurtenkov O (2012) Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj J 29(1):57\u201366. https:\/\/doi.org\/10.1007\/s10719-011-9364-z","journal-title":"Glycoconj J"},{"issue":"1","key":"7639_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ijms22010455","volume":"22","author":"K Bastian","year":"2021","unstructured":"Bastian K, Scott E, Elliott DJ, Munkley J (2021) FUT8 alpha-(1,6)-fucosyltransferase in cancer. Int J Mol Sci 22(1):455. https:\/\/doi.org\/10.3390\/ijms22010455","journal-title":"Int J Mol Sci"},{"key":"7639_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-3-030-70115-4_10","volume":"1325","author":"M Z\u0105bczy\u0144ska","year":"2021","unstructured":"Z\u0105bczy\u0144ska M, Link-Lenczowski P, Poche\u0107 E (2021) Glycosylation in autoimmune diseases. Adv Exp Med Biol 1325:205\u2013218. https:\/\/doi.org\/10.1007\/978-3-030-70115-4_10","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"7639_CR59","doi-asserted-by":"publisher","first-page":"10066","DOI":"10.3390\/ijms241210066","volume":"24","author":"CY Tsai","year":"2023","unstructured":"Tsai CY, Li KJ, Shen CY, Lu CH, Lee HT, Wu TH et al (2023) Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis. Int J Mol Sci 24(12):10066. https:\/\/doi.org\/10.3390\/ijms241210066","journal-title":"Int J Mol Sci"},{"key":"7639_CR60","doi-asserted-by":"publisher","first-page":"108201","DOI":"10.1016\/j.biotechadv.2023.108201","volume":"67","author":"M Garc\u00eda-Alija","year":"2023","unstructured":"Garc\u00eda-Alija M, van Moer B, Sastre DE, Azzam T, Du JJ, Trastoy B et al (2023) Modulating antibody effector functions by Fc glycoengineering. Biotechnol Adv 67:108201. https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108201","journal-title":"Biotechnol Adv"},{"issue":"31","key":"7639_CR61","doi-asserted-by":"publisher","first-page":"12669","DOI":"10.1073\/pnas.1108455108","volume":"108","author":"C Ferrara","year":"2011","unstructured":"Ferrara C, Grau S, J\u00e4ger C, Sondermann P, Br\u00fcnker P, Waldhauer I et al (2011) Unique carbohydrate\u2013carbohydrate interactions are required for high affinity binding between Fc\u03b3RIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A 108(31):12669\u201312674. https:\/\/doi.org\/10.1073\/pnas.1108455108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"7639_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1158\/2326-6066.Cir-14-0125","volume":"3","author":"SD Liu","year":"2015","unstructured":"Liu SD, Chalouni C, Young JC, Junttila TT, Sliwkowski MX, Lowe JB (2015) Afucosylated antibodies increase activation of Fc\u03b3RIIIa-dependent signaling components to intensify processes promoting ADCC. Cancer Immunol Res 3(2):173\u2013183. https:\/\/doi.org\/10.1158\/2326-6066.Cir-14-0125","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"7639_CR63","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1074\/mcp.RA119.001860","volume":"19","author":"TC Martin","year":"2020","unstructured":"Martin TC, \u0160imurina M, Z\u0105bczy\u0144ska M, Martinic Kavur M, Rydlewska M, Pezer M et al (2020) Decreased immunoglobulin G core fucosylation, a player in antibody-dependent cell-mediated cytotoxicity, is associated with autoimmune thyroid diseases. Mol Cell Proteomics 19(5):774\u2013792. https:\/\/doi.org\/10.1074\/mcp.RA119.001860","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"7639_CR64","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","volume":"278","author":"T Shinkawa","year":"2003","unstructured":"Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M et al (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278(5):3466\u20133473. https:\/\/doi.org\/10.1074\/jbc.M210665200","journal-title":"J Biol Chem"},{"issue":"30","key":"7639_CR65","doi-asserted-by":"publisher","first-page":"26733","DOI":"10.1074\/jbc.M202069200","volume":"277","author":"RL Shields","year":"2002","unstructured":"Shields RL, Lai J, Keck R, O\u2019Connell LY, Hong K, Meng YG et al (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277(30):26733\u201326740. https:\/\/doi.org\/10.1074\/jbc.M202069200","journal-title":"J Biol Chem"},{"issue":"18 Pt 1","key":"7639_CR66","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1158\/1078-0432.Ccr-04-0850","volume":"10","author":"R Niwa","year":"2004","unstructured":"Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A et al (2004) Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism. Clin Cancer Res 10(18 Pt 1):6248\u20136255. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-0850","journal-title":"Clin Cancer Res"},{"issue":"6","key":"7639_CR67","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/bp050228w","volume":"21","author":"J Hodoniczky","year":"2005","unstructured":"Hodoniczky J, Zheng YZ, James DC (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21(6):1644\u20131652. https:\/\/doi.org\/10.1021\/bp050228w","journal-title":"Biotechnol Prog"},{"issue":"2","key":"7639_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/antib9020022","volume":"9","author":"S Boune","year":"2020","unstructured":"Boune S, Hu P, Epstein AL, Khawli LA (2020) Principles of N-linked glycosylation variations of IgG-based therapeutics: pharmacokinetic and functional considerations. Antibodies (Basel) 9(2):22. https:\/\/doi.org\/10.3390\/antib9020022","journal-title":"Antibodies (Basel)"},{"issue":"6","key":"7639_CR69","doi-asserted-by":"publisher","first-page":"866","DOI":"10.5498\/wjp.v14.i6.866","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Sun JY, Zhang Y (2024) Effects of serum inflammatory factors, health index and disease activity scores on ankylosing spondylitis patients with sleep disorder. World J Psychiatry 14(6):866\u2013875. https:\/\/doi.org\/10.5498\/wjp.v14.i6.866","journal-title":"World J Psychiatry"},{"issue":"12","key":"7639_CR70","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1089\/omi.2024.0176","volume":"28","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xu X, Song M, Lin L (2024) Crosstalk between cytokines and IgG N-glycosylation: bidirectional effects and relevance to clinical innovation for inflammatory diseases. OMICS 28(12):608\u2013619. https:\/\/doi.org\/10.1089\/omi.2024.0176","journal-title":"OMICS"},{"issue":"1","key":"7639_CR71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12967-018-1616-2","volume":"16","author":"D Liu","year":"2018","unstructured":"Liu D, Chu X, Wang H, Dong J, Ge SQ, Zhao ZY et al (2018) The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia. J Transl Med 16(1):235. https:\/\/doi.org\/10.1186\/s12967-018-1616-2","journal-title":"J Transl Med"},{"key":"7639_CR72","doi-asserted-by":"publisher","first-page":"1188838","DOI":"10.3389\/fimmu.2023.1188838","volume":"14","author":"S Trzos","year":"2023","unstructured":"Trzos S, Link-Lenczowski P, Poche\u0107 E (2023) The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy. Front Immunol 14:1188838. https:\/\/doi.org\/10.3389\/fimmu.2023.1188838","journal-title":"Front Immunol"},{"issue":"1","key":"7639_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-025-03505-y","volume":"27","author":"X Xu","year":"2025","unstructured":"Xu X, Chen Z, Song M, Hou Z, Balmer L, Zhou C et al (2025) Profiling of IgG N-glycosylation for axial spondyloarthritis and other rheumatic diseases. Arthritis Res Ther 27(1):37. https:\/\/doi.org\/10.1186\/s13075-025-03505-y","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07639-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:01:47Z","timestamp":1761660107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07639-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["7639"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07639-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}